8-K/A

FORM 8-K AMENDMENT NO.1

Company: Lipocine Inc.
Filed: September 5, 2013
Period of Report: August 27, 2013
Accession Number: 0001193125-13-358469

View Document ↗ View on SEC.gov ↗